about
Imputation and subset based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer typesDistinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of boneA mosaic activating mutation in AKT1 associated with the Proteus syndromePotential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayPAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology groupBrachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomasGenome-wide association study identifies two susceptibility loci for osteosarcomaH3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of BoneMicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.Dedifferentiated chordoma: a report of four cases arising 'de novo'.Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.A common single-nucleotide variant in T is strongly associated with chordoma.EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
P50
Q23924183-7991B8AD-9A03-474B-8BD7-B40ACD38EF99Q24170413-D5DE0A1D-4049-496C-85FB-59D765F0ABBCQ24595521-8C42DBCF-1375-4D21-8572-28F0F94A5FA1Q24598593-25C7E06D-9C57-4D84-9A1E-D86C1C50041BQ24648029-14D324AA-96E1-4128-950B-A6BFD38B8321Q28201860-C9A43E1A-5A19-42CE-AA7E-FF8E037CDA66Q28302123-FDF5CA44-CFB4-448C-BC07-0560439DB966Q28659642-EB997240-9A13-4A9B-85B8-B67BF7A34FDCQ30491677-755945CD-623E-42B6-AFC5-A5FF7A779315Q30537249-813402B3-942D-4B12-8328-F85893BA1127Q33272617-FB6DA364-A83D-400F-9886-F6F48022673FQ33273051-64878BC5-E7C1-4943-89AC-70277DB96FE6Q33273099-53608ED9-5C9D-4DA4-B754-7697A50C7C4AQ33273364-ECF80381-6285-4A8A-8956-F95EEA1B99E4Q33274008-EB6EFE60-14DF-4BF5-85EC-00B050127185Q33274011-1B63B79A-F176-4737-8C03-5A0E2D488A99Q33274526-1347E6BB-5473-40BF-9579-96D284922B44Q33274595-2754F464-E177-4E4D-A95F-4AC283AD8810Q33276007-D3558588-CBA6-4971-8D2D-E6C480519CD3
P50
description
onderzoeker
@nl
name
Roberto Tirabosco
@ast
Roberto Tirabosco
@en
Roberto Tirabosco
@es
Roberto Tirabosco
@nl
Roberto Tirabosco
@sl
type
label
Roberto Tirabosco
@ast
Roberto Tirabosco
@en
Roberto Tirabosco
@es
Roberto Tirabosco
@nl
Roberto Tirabosco
@sl
prefLabel
Roberto Tirabosco
@ast
Roberto Tirabosco
@en
Roberto Tirabosco
@es
Roberto Tirabosco
@nl
Roberto Tirabosco
@sl